© 2001 by Oxford University Press
Journal of the National Cancer Institute, Vol. 93, No. 4, 265,
February 21, 2001
© 2001 Oxford University Press
NEWS |
Awards, Appointments, Announcements
The Cancer Research Foundation of America and the International Association for the Study of Lung Cancer have awarded two new Lung Cancer Prevention Research Fellowships.Yunfei Wang was awarded for his project "DNA Repair Variability and Lung Cancer Risk." Wang will be working on this project under the supervision of Xifeng Wu in the Department of Epidemiology at the University of Texas M. D. Anderson Cancer Center, Houston.
Fred R. Hirsch was selected for his project "Evaluation of Morphological and Cytological Criteria and Markers for Early Detection of Lung Cancer and for Monitoring Chemoprevention Studies." Hirsch will be working under the supervision of Paul A. Bunn at the University of Colorado Cancer Center in Colorado.
The fellowships were underwritten by Bristol-Myers Squibb Oncology.
Block Award Given
Donald S. Coffey, Ph.D., professor of urology at Johns Hopkins University School of Medicine, Baltimore, received the Herbert and Maxine Block Memorial Lectureship Award for Distinguished Achievement in Cancer.
Coffey is past president of the American Association for Cancer Research and former deputy director of the Johns Hopkins Oncology Center.
The Block Award is awarded by the Arthur G. James Cancer Hospital, Columbus, Ohio, in honor of Herbert J. Block.
Mihich Honored
Enrico Mihich, M.D., director of the Department of Pharmacology and Therapeutics at Roswell Park Cancer Institute, Buffalo, N.Y., received the Thomas B. Tomasi Achievement Award from the Roswell Park Alliance.
|
Mihich joined the cancer institute staff in 1957 and was named director of the Director of the Department of Experimental Therapeutics in 1971.
Rottman Appointed
The Van Andel Institute, Grand Rapids, Mich., appointed Fritz M. Rottman, Ph.D., as a trustee of the Van Andel Research Institute.
Rottman recently retired as professor and chairman of the Molecular Biology and Microbiology Department at Case Western Reserve University School of Medicine.
Coley Names Board
Coley Pharmaceutical Group, Wellesley, Mass., has appointed a four-person scientific advisory board.
The members are:
• George Demetri, M.D., co-director at the Center for Sarcoma and Bone Oncology at Dana-Farber Cancer Institute;
• Ronald Levy, M.D., chief of the Division of Oncology at Stanford University School of Medicine;
• Wolfram Sterry, M.D., professor and chairman, Department of Dermatology, Charite University Hospital, Humboldt University, Berlin; and
• Jerry Weisbach, Ph.D., former president of the Parke Davis Research Division, Warner Lambert Company.
Coley has also named Patricia F. Dimond, Ph.D., as vice president of corporate communications and strategic development.
NCCS Adds Board Members
The National Coalition for Cancer Survivorship has added four members to its board of directors. They are:
• Nancy Glick, senior counselor for health, nutrition, and consumer issues at Hill & Knowlton, an international public relations firm in Washington, D.C.;
• Virginia Knauer, who has served as special adviser to the president for consumer affairs and director of the United States Office of Consumer Affairs under Presidents Nixon, Ford, and Reagan;
• Neil Schlackman, M.D., senior corporate medical director of Aetna, fellow of the American Board of Pediatrics, and diplomat of the Board of Pediatric Hematology and Oncology; and
• Alfred E. Smith IV, managing director of Hunter Specialists, LLC, New York.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||